Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial

NCT01442727 is registered in ClinicalTrials.gov with Texas Tech University as lead sponsor.

NCT NCT01442727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01442727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selenite in the Detoxification of Arsenic and the Prevention of Arsenical Melanosis and Cancers Amongst Bangladeshi Arsenicosis Patients: A 48-week, Randomized, Double-blinded, Placebo-controlled Phase III Trial
Lead sponsor
Texas Tech University
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2006
Completion date
April 30, 2009
Enrollment
819 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arsenic exposure, arsenic poisoning, arsenic toxicity, arsenical cancers, arsenical keratosis, arsenical melanosis, arsenicosis